logo

For the Inventor, By the Inventor

Guilford, CT, United States of America

Raymond F Horvath

This inventor holds 30 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Neurogen Corporation, Pfizer Corporation, Other. Active years: 1997-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raymond F Horvath. Retrieved from https://idiyas.com/inventor/raymond-f-horvath

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30

% Patents Active = 70.0


Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 230(Granted Patents)


Location History:

  • North Brandford, CT (US) (2001)
  • North Branford, CT (US) (1997 - 2002)
  • Guilford, CT (US) (2003 - 2007)

Company Filing History:

goldMedal28 out of 305 
 
Neurogen Corporation
 patents
silverMedal1 out of 4,488 
 
Pfizer Corporation
 patents
bronzeMedal2 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1997-2007

Loading Chart...
Loading Chart...
Areas of Expertise:
CRF1 Ligands
Dopamine Receptor
Substituted Heterocycles
Aminoalkyl Compounds
Pyridine Derivatives
Imidazole Derivatives
Arylpyrazines
Tricyclic Compounds
Piperidine Derivatives
Neuropeptide Y Receptor
Benzimidazolecarboxamide
Pyrrolopyridine
30 patents (USPTO):Explore Patents
1. 7223778 - 5-substituted-2-arylpyridines (2007-05-29),
2. 7202250 - Substituted arylpyrazines (2007-04-10),
3. 7179807 - 5-substituted-2-arylpyrazines (2007-02-20),
4. 7074929 - Certain alkylene diamine-substituted heterocycles (2006-07-11),
5. 6995161 - Substituted arylpyrazines (2006-02-07),
6. 6797824 - Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands (2004-09-28),
7. 6696445 - Certain alkylene diamine-substituted heterocycles (2004-02-24),
8. 6670371 - Certain pyrrolopyridine derivatives: novel CRF1 specific ligands (2003-12-30),
9. 6583169 - N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives (2003-06-24),
10. 6506762 - Certain alkylene diamine-substituted heterocycles (2003-01-14),
11. 6472402 - Aminoalkyl substituted 5,6,7,8-Tetrahydro-9H-Pyridino [2,3-B]indole derivatives (2002-10-29),
12. 6436932 - Aminoalkyl substituted pyrrolo[3,2-e] pyridine and pyrrolo[2,3-b]pyrimidine derivatives: modulators of CRF1 receptors (2002-08-20),
13. 6362186 - Aminoalkyl substituted 9H-phridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives (2002-03-26),
14. 6358955 - Substituted imidazoles as subtype specific dopamine receptor ligands and pharmaceutical compositions containing such substituted imidazole (2002-03-19),
15. 6355651 - Certain pyrrolopyridine derivatives; novel CRF1 specific ligands (2002-03-12),

Title: Raymond F Horvath - Pioneering Inventor from Guilford, CT

Introduction: Raymond F Horvath is a distinguished inventor hailing from Guilford, CT, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Raymond F Horvath holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing cutting-edge solutions for modern challenges.

Career Highlights: Throughout his illustrious career, Raymond F Horvath has consistently pushed the boundaries of innovation, with a focus on developing practical inventions that have the potential to revolutionize industries.

Collaborations: Raymond F Horvath has collaborated with leading research institutions, universities, and companies to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Raymond F Horvath's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, inspiring the next generation of innovators to push the limits of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…